2-151727817-TGCTGGCTGTGCCAGA-TGCTGGCTGTGCCAGAGCTGGCTGTGCCAGA
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP3BP6BS1BS2
The NM_001164508.2(NEB):c.167_168insTCTGGCACAGCCAGC(p.Leu57_Ala61dup) variant causes a inframe insertion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00114 in 1,604,630 control chromosomes in the GnomAD database, including 15 homozygotes. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.00062 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0012 ( 14 hom. )
Consequence
NEB
NM_001164508.2 inframe_insertion
NM_001164508.2 inframe_insertion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.768
Genes affected
NEB (HGNC:7720): (nebulin) This gene encodes nebulin, a giant protein component of the cytoskeletal matrix that coexists with the thick and thin filaments within the sarcomeres of skeletal muscle. In most vertebrates, nebulin accounts for 3 to 4% of the total myofibrillar protein. The encoded protein contains approximately 30-amino acid long modules that can be classified into 7 types and other repeated modules. Protein isoform sizes vary from 600 to 800 kD due to alternative splicing that is tissue-, species-,and developmental stage-specific. Of the 183 exons in the nebulin gene, at least 43 are alternatively spliced, although exons 143 and 144 are not found in the same transcript. Of the several thousand transcript variants predicted for nebulin, the RefSeq Project has decided to create three representative RefSeq records. Mutations in this gene are associated with recessive nemaline myopathy. [provided by RefSeq, Sep 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP3
Nonframeshift variant in repetitive region in NM_001164508.2
BP6
Variant 2-151727817-T-TGCTGGCTGTGCCAGA is Benign according to our data. Variant chr2-151727817-T-TGCTGGCTGTGCCAGA is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 419871.We mark this variant Likely_benign, oryginal submissions are: {Benign=2, Uncertain_significance=1, Likely_benign=2}.
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.000622 (92/147970) while in subpopulation SAS AF= 0.0116 (56/4826). AF 95% confidence interval is 0.00918. There are 1 homozygotes in gnomad4. There are 55 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAdExome4 at 14 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NEB | NM_001164507.2 | c.167_168insTCTGGCACAGCCAGC | p.Leu57_Ala61dup | inframe_insertion | 5/182 | ENST00000427231.7 | NP_001157979.2 | |
NEB | NM_001164508.2 | c.167_168insTCTGGCACAGCCAGC | p.Leu57_Ala61dup | inframe_insertion | 5/182 | ENST00000397345.8 | NP_001157980.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NEB | ENST00000397345.8 | c.167_168insTCTGGCACAGCCAGC | p.Leu57_Ala61dup | inframe_insertion | 5/182 | 5 | NM_001164508.2 | ENSP00000380505 | P5 | |
NEB | ENST00000427231.7 | c.167_168insTCTGGCACAGCCAGC | p.Leu57_Ala61dup | inframe_insertion | 5/182 | 5 | NM_001164507.2 | ENSP00000416578 | A2 | |
NEB | ENST00000409198.5 | c.167_168insTCTGGCACAGCCAGC | p.Leu57_Ala61dup | inframe_insertion | 5/150 | 5 | ENSP00000386259 |
Frequencies
GnomAD3 genomes AF: 0.000615 AC: 91AN: 147858Hom.: 1 Cov.: 32
GnomAD3 genomes
AF:
AC:
91
AN:
147858
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00154 AC: 379AN: 246372Hom.: 5 AF XY: 0.00197 AC XY: 264AN XY: 133888
GnomAD3 exomes
AF:
AC:
379
AN:
246372
Hom.:
AF XY:
AC XY:
264
AN XY:
133888
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00119 AC: 1736AN: 1456660Hom.: 14 Cov.: 31 AF XY: 0.00147 AC XY: 1062AN XY: 724714
GnomAD4 exome
AF:
AC:
1736
AN:
1456660
Hom.:
Cov.:
31
AF XY:
AC XY:
1062
AN XY:
724714
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000622 AC: 92AN: 147970Hom.: 1 Cov.: 32 AF XY: 0.000760 AC XY: 55AN XY: 72390
GnomAD4 genome
AF:
AC:
92
AN:
147970
Hom.:
Cov.:
32
AF XY:
AC XY:
55
AN XY:
72390
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Asia WGS
AF:
AC:
16
AN:
3478
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:5
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Uncertain:1Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 19, 2020 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Sep 12, 2016 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Nov 30, 2017 | - - |
Nemaline myopathy 2 Benign:3
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Likely benign, no assertion criteria provided | clinical testing | Natera, Inc. | Jan 06, 2020 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jun 10, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at